RespireRx Pharmaceuticals Inc (fka RSPI)

[enemem]

"bad data" is ill-defined here: even if there was a positive trend, with an n this small, the trend is unlikely to be statistically significant, hence technically, this would constitute bad data. With the same n, if there is no trend or a negative trend, it would nonetheless be indistinguishable from the good "bad data", since both would fail to reach statistical significance. I think burying it would not be legally actionable. The only consequence is that SA would not be a factor in valuation discussions.